Learn about semaglutide (Ozempic), how it works, its clinical evidence, and the current regulatory status in Zimbabwe. This is an educational resource only.
Ozempic is a registered trademark of Novo Nordisk. This website is not affiliated with Novo Nordisk and does not sell any medications. Ozempic is not currently registered with MCAZ (Medicines Control Authority of Zimbabwe).
Ozempic is a brand name for semaglutide, a medication developed by Novo Nordisk for treating type 2 diabetes and chronic weight management.
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist. It works by mimicking a natural hormone in your body that:
Signals to the brain that you're full, reducing hunger and food intake
Food stays in the stomach longer, promoting satiety after meals
Helps the body produce insulin when blood sugar is high
Over 68 weeks in STEP 1 trial
Source: STEP 1 Clinical Trial, New England Journal of Medicine, 2021
Administered once per week via subcutaneous injection
Starts low and increases over weeks to minimize side effects
Must be prescribed and monitored by a healthcare provider
Understanding the legal and regulatory framework for Ozempic in Zimbabwe.
As of January 2026, Ozempic (semaglutide) is not registered with the Medicines Control Authority of Zimbabwe (MCAZ). This means:
The Medicines Control Authority of Zimbabwe (MCAZ) is responsible for regulating medicines, medical devices, and allied substances in Zimbabwe. All pharmaceutical products must be registered with MCAZ before they can be legally sold in the country.
Official Website: www.mcaz.co.zw
You can verify if a medication is registered in Zimbabwe by checking the MCAZ registered medicines database.
Ozempic has been approved in many countries for diabetes and/or weight management, including:
Understanding the medication behind the brand names Ozempic, Wegovy, and Rybelsus.
Semaglutide is the active pharmaceutical ingredient (API) used in several brand-name medications:
Injectable, for type 2 diabetes
Injectable, for weight management
Oral tablet, for type 2 diabetes
All three are manufactured by Novo Nordisk and contain semaglutide as the active ingredient, but are formulated differently and approved for different uses.
In some countries, compounding pharmacies may prepare semaglutide formulations. Important considerations:
Since Ozempic is not available in Zimbabwe, here are resources to explore legitimate weight management options.
zimtrim.com
Weight loss solutions and resources for Zimbabweans.
zimweightloss.com
Comprehensive weight management resources for Zimbabwe.
While pharmaceutical options may be limited, these approaches are proven effective for weight management:
Work with a doctor or registered dietitian to create a personalized plan
Focus on whole foods, portion control, and sustainable eating habits
Aim for 150+ minutes of moderate activity per week
Consider counseling or support groups for sustainable lifestyle changes
Common questions about Ozempic availability in Zimbabwe.
No. Ozempic is not registered with the Medicines Control Authority of Zimbabwe (MCAZ) and therefore cannot be legally sold in Zimbabwe. Any product claiming to be Ozempic sold within Zimbabwe may be counterfeit or illegally imported, which poses serious health risks.
Importing unregistered medications into Zimbabwe is regulated by MCAZ. You should consult with MCAZ directly or a healthcare professional about the legal requirements for importing prescription medications for personal use. Self-importation of medications carries risks including customs seizure and potential health risks from improper storage during transit.
Consult with a Zimbabwean healthcare provider about MCAZ-approved weight management options. These may include other medications, supervised diet programs, or referral to specialists. Websites like ZimTrim and Zim Weight Loss may provide additional resources specific to Zimbabwe.
Pharmaceutical companies must apply for registration with each country's regulatory authority. The registration process involves submitting extensive documentation about safety, efficacy, and manufacturing quality. Novo Nordisk, the manufacturer of Ozempic, may not have applied for registration in Zimbabwe due to market size considerations, or an application may be pending. For the latest status, check with MCAZ directly.
Purchasing unverified medications carries serious risks including:
No. This website is for educational purposes only. We do not sell, supply, distribute, or facilitate the purchase of Ozempic or any other medication. We provide information about semaglutide/Ozempic and direct visitors to legitimate resources and alternatives.